Molecular imaging study reveals improved detection of early recurrent prostate cancer

17 septiembre 2015

A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, researchers report. The American Cancer Society reports that prostate cancer is the second leading cause of cancer death in American men, behind lung cancer, with about 220,800 new cases estimated in 2015.